Archives
Categories
New Cancer Genetics Clinic Opens at The Mater Private Hospital
Wednesday, February 2nd, 2011The Mater Private Hospital has officially opened a new Cancer Genetics Clinic which will be headed up by Dr. David Gallagher, who dual trained in medical oncology and genetics and has recently joined The Mater Private Hospital from the world renowned Memorial Sloan-Kettering Cancer Centre in New York. Also joining The Mater Private team is experienced cancer genetics Clinical Nurse Specialist Mr. Michael Farrell, who was previously based at St. James Hospital, Dublin.
The primary aim of the new cancer genetics service at the Mater Private Hospital is to offer preventative care for individuals who have an increased risk of developing cancer. An increased understanding of hereditary predisposition to cancer is providing a new direction in cancer treatment, particularly with respect to diagnosis, management and ultimately prevention. The goal of cancer genetics, which is an expanding area of clinical practice, is to reduce mortality among high risk individuals.
The process begins by recording accurate data on family members, both those affected by cancer and those unaffected. This is traced through at least three generations, with the emphasis on the types of cancer and the age at diagnosis. Hereditary breast ovarian cancer syndrome and Lynch syndrome are the two commonest cancer predisposition syndromes that are tested for in a cancer genetics clinic, but many other tests for rare cancer predisposition syndromes are clinically available. Breast cancer is the malignancy that most commonly leads to a cancer genetics referral. The clinical features that should lead to suspicion of inherited predisposition to breast cancer for example are early age at onset, cancer in both breasts, multiple cases of breast and ovarian cancer in the family, male breast cancer and breast and ovarian cancer in the same individual.
Speaking about the launch of the new cancer genetics clinic, Dr. David Gallagher said
“From my experience at Memorial Sloan Kettering, I believe that improved access to cancer genetics services and integration of these services into designated cancer centres can meaningfully contribute to cancer prevention in Ireland. The provision of risk assessment and prevention counseling services is paramount to the success of a comprehensive cancer care programme. The addition of a genetics service provides a preventive as well as personalised medicine component to The Mater Private Cancer Centre. Increased awareness of hereditary predisposition has increased demand for genetic counselling and genetic testing, and improved access to this service is imperative to allow affected families avail of cancer prevention and early-detection methods. Timely intervention will help individuals with a genetic risk of cancer to clarify their risk status and ultimately reduce morbidity and mortality, prolong life. Women receiving positive genetic test results have cited relief from uncertainty and anxiety and consider the knowledge gained a positive factor in the ability to make active decisions about their healthcare. The decision as to whether to pursue a screening or preventive surgery strategy is often determined by the individual’s perception of risk which in turn may be influenced by their personal and/or family experience of cancer.
“For others, a more positive outcome from genetics testing, i.e. where no mutation is found, alleviates a great deal of stress and worry about cancer. The emphasis is firmly on ensuring that the process remains voluntary throughout, i.e. that the individual can opt out of the process at any stage. However, genetic counselling and testing also empowers high risk individuals to take greater control of the management of their health.”
Clinical Nurse Specialist Michael Farrell said
“It is important to listen carefully to the individual and assess perceptions of cancer risk, learn of prior experiences with cancer within the family and provide an ample opportunity for questions to be asked and allow a truly informed decision to be made. Both individuals and families experience various psychological reactions in the context of genetic testing and issues frequently arise that offer challenges to health carers involved in this area. Many have lingering hurt and unresolved grief relating to cancer diagnoses and deaths within their families and these issues frequently surface during discussions. Emotional reactions can range from anxiety and fear to depression and loss of self esteem. The objective of the genetic counsellor is to help the person manage all of these issues and come to a decision which achieves the right outcome for each individual.”
The Mater Private Cancer Genetics Clinic is now open to referrals. The clinic can be contact at 01 8858433, Dr. David Gallagher, Medical Oncologist and Medical Geneticist, can be contacted at 01 8858883 and Mr. Michael Farrell, Genetics Counsellor, at 01 8858398.
Posted in Cancer Centre, Main | No Comments »
Mater Private Cancer Centre – New Robotic Assisted Surgical Programme
Monday, November 1st, 2010Mater Private Hospital Launches Ireland’s First Multi-Speciality Robotic Assisted Surgical Programme
Mater Private invests €2 million in da Vinci surgical robot to facilitate best clinical outcomes for patients
The Mater Private Hospital, one of Europe’s leading private hospitals, today launched Ireland’s first multi-specialty robotic assisted surgical programme which will enable surgeons to deliver the best possible outcomes for patients across a range of surgical procedures. Using the da Vinci Surgical System, the Mater Private Hospital is one of a select group of hospitals in the world that will offer superior three dimensional, high definition visualisation during Urology, Gynaecology and Colorectal surgical procedures, as well as enhanced dexterity which ensures greater precision. Surgeons at the Mater Private Hospital will use this leading technology to perform complex procedures such as prostatectomy, hysterectomy and colon resection. As the procedures are less invasive than traditional surgeries, patient outcomes are superior with reduced incidence of complications and faster recovery times.
Fergus Clancy, Chief Executive at The Mater Private Hospital explained:
“We are proud to offer the option of this exciting technology to such a wide range of patient groups across a number of specialities. The hospital Urology programme is already well established with over 40 patients having already successfully undergone robotic assisted prostatectomy. Urologists, Professor John Fitzpatrick and Mr Kiaran O’Malley at the Mater Private are currently providing this service. A number of Gynaecology and Colorectal surgeons at the Mater Private are now in the process of training on the system so that the technology will also be available to patients as an alternative to both open and laparoscopic surgery. The Mater Private Hospital is a hi-tech hospital, committed to providing leading edge medical technology and ensuring that patients in Ireland can have the best possible clinical outcomes. We certainly have achieved this with the robotic assisted surgical programme.”
Consultant Surgeon, Mr. Kiaran O’Malley said:
“There are significant benefits to minimally invasive procedures using this technology, including less pain, less blood loss and less need for blood transfusions. Less invasive surgery also means a shorter stay in hospital for the patient, as well as a quicker recovery and a more rapid return to normal daily activities. The Mater Private is a Centre of Excellence for prostate robotic surgery; in addition to its own campus based surgeons we have visiting Consultants from other major Dublin teaching hospitals attending the hospital exclusively to use the technology on their own cohort of patients.”
Most private health insurance plans cover 90% to 100% of the costs of robotic prostate surgery at The Mater Private Hospital, for further information on insurance cover call 01-885 8785.
Posted in Cancer Centre | No Comments »
Cancer Centre announce arrival of new consultant – Dr David Gallagher
Friday, October 29th, 2010
Dr David Gallagher originally trained on the Irish specialist registrar training scheme in medical oncology and previously worked on the Mater campus prior to spending the last number of years working at Memorial Sloan-Kettering Cancer Center in New York. He joined the Mater Private Cancer Centre team in late 2010. Dr. Gallagher is a medical oncologist with clinical experience treating a wide variety of malignancies. His research has focused on genitourinary, gynaecological, breast and colorectal cancer. He has a specialist interest in cancer genetics and hereditary predisposition to cancer, and is developing a Cancer Genetics Clinic at the Mater Private Hospital.
Posted in Cancer Centre | No Comments »
Rapid Access/Direct Referral Colposcopy Clinic at the Mater Private Cancer Centre
Wednesday, October 27th, 2010
The hospital established a dedicated direct referral Colposcopy Clinic, developed and run by Consultant Gynaecologists Bill Boyd and Tom Walsh. The Colposcopy Clinic has been established in line with National Cancer Control Programme standards and offers rapid access for women requiring this service. The Consultants will now see colposcopy referrals in the centre instead of their rooms; the nursing and administration support ensures a seamless and efficient service. For GPs it is important to know that the accreditation process is underway so that these patients are captured on the national cervical check database.
Posted in Cancer Centre | No Comments »



